Assembly Biosciences, Inc. Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Assembly Biosciences, Inc. (ASMB) had Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount of $18.10 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions · last filed 2026-08-13
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $18.10M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $14.80M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $4.60M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $5.90M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $18.10M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $14.80M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.60M 10-K · filed 2026-03-19 |
| 2025-09-30 | $5.90M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $7.50M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $4.20M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.30M 10-K · filed 2025-03-20 |
| 2024-09-30 | $2.90M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.70M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.20M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.90M 10-K · filed 2024-03-28 |
| 2023-09-30 | $3.70M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $5.00M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $7.10M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $7.70M 10-K · filed 2023-03-22 |
| 2022-09-30 | $10.90M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $9.20M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $10.90M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $9.70M 10-K · filed 2022-03-11 |
| 2021-09-30 | $12.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $14.50M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $18.60M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $20.40M 10-K · filed 2021-02-25 |
| 2020-09-30 | $27.80M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $32.20M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $34.50M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $27.50M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |